DGAP-News: Medios AG / Key word(s): Regulatory Approval
Medios AG moves to the Prime Standard stock exchange segment
Berlin, 29 May 2020 – Medios AG, one of the leading Specialty Pharma companies in Germany, was today admitted to the sub-segment of the Regulated Market with additional post-admission obligations (Prime Standard) of the Frankfurt Stock Exchange. Thus, the Medios shares are now traded in the segment with the highest transparency and disclosure requirements in Europe. Previously, Medios was listed in the General Standard of the Regulated Market.
Matthias Gärtner, CFO of Medios AG: ‘With the move to the Prime Standard, Medios fulfils the prerequisite for the admission into a selection index of Deutsche Börse. An inclusion in the SDAX would significantly increase the visibility of Medios and the attractiveness of the share for investors.’
By mid-May 2020, Medios had already achieved an important interim goal on its way to an SDAX inclusion as a result of the successful placement of 600,000 existing shares. The shares had been sold to international institutional investors in a private placement. Free float meanwhile increased from 57% to above 62%, in particular as a result of the placement, contributing to an improved liquidity of the stock.
About Medios AG
Medios AG is Germany’s first publicly listed Specialty Pharma company. The shares (ISIN: DE000A1MMCC8, DE000A288821) are listed in the Regulated Market of the Frankfurt Stock Exchange (Prime Standard).
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Phone:||+49 30 232 566 – 800|
|Fax:||+49 30 232 566 – 801|
|Listed:||Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Dusseldorf|
|EQS News ID:||1059169|
|End of News||DGAP News Service|